The FDA announced on 2022-12-22 that AVKARE LLC voluntarily recalled Glycopyrrolate Tablets, USP, 1 mg due to failed impurities and degradation specifications. The recall affects 1,237 cartons distributed nationwide.
How to tell if you have it
- Brand: AVKARE
- Product: Glycopyrrolate Tablets, USP, 1 mg, 50 Tablets (5x10) Unit Dose carton
- NDC: 50268-363-15
- Lot codes: 43313, 43342
- Expiration date: 12/2023
- Distribution: USA Nationwide
The hazard
The recalled tablets are out of specification for unknown impurities. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show AVKARE LLC has two other recalls on record since 2023-06-13. On 2023-08-11, the company recalled Sodium Fluoride Toothpaste due to wrong labeling risk. Other recent recalls of similar products include Novadoz Glycopyrrolate Oral Solution Recall (2025-12-15), AvKARE Rosuvastatin Tablets 10mg Recall (2025-12-31), and Sun Pharmaceutical Fluocinolone Acetonide Solution Recall (2025-12-30).